{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T13:38:19Z","timestamp":1777124299485,"version":"3.51.4"},"reference-count":21,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,8,26]],"date-time":"2016-08-26T00:00:00Z","timestamp":1472169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Santen Pharmaceutical Co., Ltd. (Osaka, Japan)"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.alit.2016.08.011","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T09:19:36Z","timestamp":1476091176000},"page":"338-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis"],"prefix":"10.1016","volume":"66","author":[{"given":"Yoshiaki","family":"Tagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Nakazono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiju","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.alit.2016.08.011_bib1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2332\/allergolint.11-RAI-0335","article-title":"Japanese guideline for allergic conjunctival diseases","volume":"60","author":"Takamura","year":"2011","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2016.08.011_bib2","first-page":"59","article-title":"[Clinical analysis of allergic rhinitis (pollinosis) in Hokkaido]","volume":"54","author":"Abe","year":"2005","journal-title":"[Jpn J Allergol]"},{"key":"10.1016\/j.alit.2016.08.011_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1398-9995.1998.tb03932.x","article-title":"Pollen-related allergy in Europe","volume":"53","author":"D'Amato","year":"1998","journal-title":"Allergy"},{"key":"10.1016\/j.alit.2016.08.011_bib4","first-page":"1446","article-title":"In\u00a0vitro and in\u00a0vivo studies of the non-sedating antihistamine epinastine","volume":"38","author":"F\u00fcgner","year":"1988","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.alit.2016.08.011_bib5","first-page":"365","article-title":"Antiallergic effect of epinastine: the elucidation of the mechanism","volume":"39","author":"Tasaka","year":"1990","journal-title":"Pharmacometrics"},{"key":"10.1016\/j.alit.2016.08.011_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1254\/jjp.78.11","article-title":"Pharmacological studies on the novel antiallergic drug HQL-79: II. elucidation of mechanisms for antiallergic and antiasthmatic effects","volume":"78","author":"Matsushita","year":"1998","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.alit.2016.08.011_bib7","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.anai.2014.07.007","article-title":"Efficacy of epinastine hydrochloride ophthalmic solution in allergic conjunctivitis by conjunctival cedar pollen allergen challenge","volume":"113","author":"Fujishima","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.alit.2016.08.011_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/archopht.1990.01070030090035","article-title":"Conjunctival allergen challenge: a clinical approach to studying allergic conjunctivitis","volume":"108","author":"Abelson","year":"1990","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.alit.2016.08.011_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256450","article-title":"Endogenous histamine and cortisol levels in subjects with different histamine N-methyltransferase C314T genotypes: a pilot study","volume":"10","author":"Hon","year":"2006","journal-title":"Mol Diagn Ther"},{"key":"10.1016\/j.alit.2016.08.011_bib10","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1016\/S0149-2918(03)80315-6","article-title":"Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans","volume":"25","author":"Leonardi","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.alit.2016.08.011_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1600-0420.1999.tb01172.x","article-title":"Comparison of the conjunctival allergen challenge model with the environmental model of allergic conjunctivitis","volume":"228","author":"Abelson","year":"1999","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.alit.2016.08.011_bib12","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s11882-003-0100-z","article-title":"Conjunctival allergen challenge: models in the investigation of ocular allergy","volume":"3","author":"Abelson","year":"2003","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.alit.2016.08.011_bib13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2332\/allergolint.55.157","article-title":"Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis","volume":"55","author":"Takamura","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2016.08.011_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12325-014-0156-2","article-title":"Efficacy of olopatadine versus epinastine for treating allergic conjunctivitis caused by Japanese cedar pollen: a double-blind randomized controlled trial","volume":"31","author":"Fukushima","year":"2014","journal-title":"Adv Ther"},{"key":"10.1016\/j.alit.2016.08.011_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00484-002-0154-y","article-title":"Responses in the start of Betula (birch) pollen seasons to recent changes in spring temperatures across Europe","volume":"47","author":"Emberlin","year":"2003","journal-title":"Int J Biometeorol"},{"key":"10.1016\/j.alit.2016.08.011_bib16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2332\/allergolint.09-RAI-0136","article-title":"Oral allergy syndrome","volume":"58","author":"Kondo","year":"2009","journal-title":"Allergol Int"},{"key":"10.1016\/j.alit.2016.08.011_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000321819","article-title":"Detection of Bet v1, Bet v2 and Bet v4 specific IgE antibodies in the sera of children and adult patients allergic to birch pollen: evaluation of different IgE reactivity profiles depending on age and local sensitization","volume":"154","author":"Sekerkov\u00e1","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.alit.2016.08.011_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0149-2918(04)90004-5","article-title":"Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitis","volume":"26","author":"Abelson","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.alit.2016.08.011_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajo.2010.10.001","article-title":"Pre-seasonal treatment with topical olopatadine suppresses the clinical symptoms of seasonal allergic conjunctivitis","volume":"151","author":"Shimura","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.alit.2016.08.011_bib20","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.intimp.2013.02.009","article-title":"Usefulness of HeLa cells to evaluate inverse agonistic activity of antihistamines","volume":"15","author":"Mizuguchi","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.alit.2016.08.011_bib21","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1254\/jphs.08222FP","article-title":"Repeated pre-treatment with antihistamines suppresses [corrected] transcriptional up-regulations of histamine H(1) receptor and interleukin-4 genes in toluene-2,4-diisocyanate-sensitized rats","volume":"108","author":"Mizuguchi","year":"2008","journal-title":"J\u00a0Pharmacol Sci"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893016301307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1323893016301307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:08:06Z","timestamp":1761156486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893016301307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1323893016301307"],"URL":"https:\/\/doi.org\/10.1016\/j.alit.2016.08.011","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis","name":"articletitle","label":"Article Title"},{"value":"Allergology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.alit.2016.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017, Japanese Society of Allergology. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}